Tocilizumab (monoclonal anti-IL-6R antibody) reverses anlotinib resistance in osteosarcoma

Jiuhui Xu(Peking University), Xiaodong Tang(Peking University)
Frontiers in Oncology
June 19, 2023
Cited by 7


Related Papers